Page last updated: 2024-11-04

sulfamethazine and Acute Myelogenous Leukemia

sulfamethazine has been researched along with Acute Myelogenous Leukemia in 1 studies

Sulfamethazine: A sulfanilamide anti-infective agent. It has a spectrum of antimicrobial action similar to other sulfonamides.
sulfamethazine : A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rose, MS1
Black, PJ1
Barkhan, P1

Other Studies

1 other study available for sulfamethazine and Acute Myelogenous Leukemia

ArticleYear
Fatal outcome after combined therapy for myeloblastic leukaemia and toxoplasmosis.
    Lancet (London, England), 1973, Mar-17, Volume: 1, Issue:7803

    Topics: Aged; Antineoplastic Agents; Bone Marrow Diseases; Cytarabine; Daunorubicin; Humans; Leukemia, Myelo

1973